SCHD vs SPXT
Schwab US Dividend Equity ETF vs ProShares S&P 500 Ex-Technology ETF
Which is better, SCHD or SPXT?
Large Cap Value against Large Cap Blend.
SCHD has a lower expense ratio. SCHD led over 1Y, 3Y, 5Y and the full window. SPXT is less concentrated, with 30.4% of the fund in its ten largest positions against 41.8%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | SCHD | SPXT |
|---|---|---|
| Expense Ratio | 0.06%Best | 0.09% |
| AUM | $112.1B | $295M |
| Dividend Yield | 3.00% | 1.33% |
| Holdings | 103 | 430 |
| YTD Return | +25.84%Best | +6.22% |
| 1Y Return | +30.18%Best | +10.35% |
| 3Y Return (annualized) | +16.08%Best | +15.64% |
| 5Y Return (annualized) | +9.97%Best | +9.02% |
| Volatility (annualized) | 14.9% | 14.4%Best |
| Max Drawdown | -33.4%Best | -34.4% |
| $10,000 over 5 years | $16,083Best | $15,400 |
| Top 10 Weight | 41.8% | 30.4%Best |
| Fund Family | Charles Schwab Asset Management | ProShares |
| Category | Equity | Equity |
| Style | Large Cap Value | Large Cap Blend |
| Inception | Oct 20, 2011 | Sep 22, 2015 |
Volatility and max drawdown are measured over the window both funds cover: Sep 24, 2015 to Sep 15, 2026 (11 years).
SCHD vs SPXT growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 11 years both funds cover.
SCHD vs SPXT Performance
Schwab US Dividend Equity ETF (SCHD) is an ETF from Charles Schwab Asset Management and ProShares S&P 500 Ex-Technology ETF (SPXT) is an ETF from ProShares. Over the past year SCHD returned +30.18% while SPXT returned +10.35%. Year to date, SCHD is up 25.84% versus a gain of 6.22% for SPXT.
Over three years, SCHD compounded at +16.08% per year against +15.64% for SPXT; over five years the annualized figures are +9.97% and +9.02% respectively. Across the full 11-year window we track, SCHD has the edge at +12.07% annualized vs +10.50%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
SCHD has been the more volatile fund, with annualized monthly volatility of 14.9% compared with 14.4% for SPXT. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -33.4% for SCHD and -34.4% for SPXT. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.89. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
SCHD charges 0.06% per year while SPXT charges 0.09%. On a $10,000 position that is $6 vs $9 annually, a gap of $3 per year that compounds over a long holding period. On income, SCHD currently yields 3.00% against 1.33% for SPXT.
Holdings Overlap
86.1% of SCHD's money is in holdings SPXT also owns. 11.6% of SPXT's money is in holdings SCHD also owns.
Most of SCHD is already inside SPXT. Owning both mostly buys the same companies twice.
42 positions in common, counted across the 100 positions we hold weights for in SCHD and 429 in SPXT, against full books of 103 and 430.
What only one of them owns
Our book lists 377 positions for SPXT that do not appear in our book for SCHD (87.2% of the fund), and 57 for SCHD that do not appear in SPXT (13.8%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in SCHD | Weight in SPXT | Difference |
|---|---|---|---|
| MRKMerck & Company Inc | 4.77% | 0.89% | 3.88% |
| AMGNAmgen Inc. | 4.70% | 0.56% | 4.14% |
| ABTAbbott Laboratories | 4.69% | 0.47% | 4.22% |
| KOCoca Cola Co. | 4.17% | 0.83% | 3.34% |
| CVXChevron Corp | 4.02% | 0.94% | 3.08% |
| UNHUnitedhealth Group Incorporated | 3.82% | 0.86% | 2.96% |
| HDHome Depot Inc/The | 3.88% | 0.79% | 3.09% |
| PGProcter & Gamble Company | 3.83% | 0.82% | 3.01% |
| VZVerizon Communic | 3.97% | 0.51% | 3.46% |
| COPConocophillips Common Stock USD 0.01 | 3.94% | 0.39% | 3.55% |
86.1% of SCHD is already inside SPXT.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, SCHD or SPXT?
SCHD has an expense ratio of 0.06% while SPXT charges 0.09%. SCHD is the cheaper option, by $3 a year on a $10,000 investment.
Which performed better, SCHD or SPXT?
Over the past year SCHD returned +30.18% vs +10.35% for SPXT, so SCHD leads on 1-year performance. Over the longest common window we track (11 years), SCHD annualized +12.07% vs +10.50% for SPXT. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, SCHD or SPXT?
SCHD has been the more volatile fund at 14.9% annualized versus 14.4% for SPXT. Worst drawdown: SCHD -33.4% vs SPXT -34.4%.
Should I hold both SCHD and SPXT?
SCHD and SPXT have a monthly-return correlation of 0.89, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between SCHD and SPXT?
86.1% of SCHD's money is in holdings SPXT also owns. 11.6% of SPXT's is in holdings SCHD also owns. They hold 42 positions in common, counted across the 100 positions we hold weights for in SCHD and 429 in SPXT.
Which pays a higher dividend, SCHD or SPXT?
SCHD yields 3.00% while SPXT yields 1.33%, so SCHD currently pays the higher dividend yield.
Is SPXT better than SCHD?
SCHD has a lower expense ratio. SCHD led over 1Y, 3Y, 5Y and the full window. SPXT is less concentrated, with 30.4% of the fund in its ten largest positions against 41.8%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.